GO
Loading...

Medicaid

More

  • March 27- A federal data-sharing system meant to prevent healthcare providers banned from one state's Medicaid program from billing another state's program isn't working as intended, according to the U.S. Department of Health and Human Services Office of the Inspector General.

  • March 27- A federal data-sharing system meant to prevent healthcare providers banned from one state's Medicaid program from billing another state's program isn't working as intended, according to the U.S. Department of Health and Human Services Office of the Inspector General.

  • MINNEAPOLIS, MN, March 25, 2014-- VigiLanz, a digital healthcare technology company headquartered in Minneapolis, announced today that its real-time clinical surveillance and quality software-as-a-service platform is compliant and prepared for the changes in the Centers for Medicare and Medicaid Services ICD-9 coding, used to report medical diagnosis and inpatient procedures, to the new ICD-10 codes, which go into effect October 1, 2014. The new expanded coding has been designed to make the billing process more accurate, streamlined and efficient, and allow for greater specificity and exactness in describing a patient's diagnosis and in classifying inpatient procedures.

  • March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 8 percent, Amgen Inc dropped 3 percent and Celgene Corp lost 3.7 percent.

  • March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 6 percent, Amgen Inc dropped 2.5 percent and Celgene Corp was down 2 percent.

  • Gilead takes heat: Waxman ignites debate on drugs Friday, 21 Mar 2014 | 12:30 PM ET
    Rep. Henry Waxman in July 2013.

    Biotechs drop on reports Rep. Waxman has sent a letter to Gilead's CEO asking him to justify the price of Hepatitis C drug Sovaldi.

  • DANVERS, Mass., March 21, 2014-- Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced that the Centers for Medicare& Medicaid Services has released an updated version of ICD-10 MS-DRGs and maintained assignment to Diagnosis Related Groups 216-221 for the category of devices that includes Impella ® pumps.

  • Watch out for late fees: No more Obamacare delays Thursday, 13 Mar 2014 | 10:47 AM ET
    Health and Human Services Secretary Kathleen Sebelius.

    There will be no delay in penalty for missing the health care enrollment deadline, U.S. Health and Human Services Secretary Kathleen Sebelius said.

  • PHILADELPHIA, PA., March 13, 2014-- With the end of the first open enrollment period under the Affordable Care Act just 18 days away, Independence Blue Cross is hosting an all-day enroll-a-thon today to help individuals get the coverage they need under the new health care law before the March 31 deadline.

  • WASHINGTON, March 12- There will be no delay in the penalty most Americans face under President Barack Obama's healthcare reform law if they fail to obtain health coverage this year, U.S. Health and Human Services Secretary Kathleen Sebelius said on Wednesday.

  • WASHINGTON, March 12- There will be no delay in the penalty most Americans face under President Barack Obama's healthcare reform law if they fail to obtain health coverage this year, U.S. Health and Human Services Secretary Kathleen Sebelius said on Wednesday.

  • LINCOLN, Neb., March 12, 2014-- Ryan Larsen, President for Veolia's IntelliRide Division, announced this week that Veolia has been awarded the company's first state-wide Medicaid brokerage contract.

  • WASHINGTON, March 11 (Reuters)- The Obama administration said on Tuesday that 4.2 million people have signed up for private health insurance under Obamacare, and indicated that total enrollment could surpass a 6 million-enrollee forecast by the end of March.

  • March 11- Teva Pharmaceutical Industries Ltd agreed to pay $27.6 million to settle charges that it paid kickbacks to a Chicago psychiatrist to induce him to prescribe an anti-schizophrenia drug to patients, resulting in more than 100,000 false Medicaid and Medicare claims.

  • US drops changes for Medicare drug benefits Monday, 10 Mar 2014 | 2:58 PM ET

    The Medicare Part D prescription drug program will not be immediately changed by the Obama administration.

  • WASHINGTON, March 10- The Obama administration on Monday pulled back from possible changes to the popular Medicare Part D prescription drug program, saying it would not finalize proposals that have spawned fierce opposition from a broad coalition of interests.

  • WASHINGTON, March 10- The Obama administration on Monday told members of Congress that it will not finalize controversial changes to the Medicare Part D prescription drug benefits program "at this time," following weeks of growing opposition to the proposals from a broad coalition of interests.

  • U.S. official in charge of Obamacare exchanges resigns Thursday, 6 Mar 2014 | 5:33 PM ET

    WASHINGTON, March 6- A top U.S. healthcare official, accused by Republicans of misleading Congress about the readiness of the Obamacare rollout, will resign from his post at the end of March, officials said on Thursday.

  • Several insurers, including Molina Healthcare, which administer health plans for California's Medicaid program for the poor are asking states to step in and pay for Gilead Sciences Inc's Sovaldi, a drug that costs $84,000 per patient.

  • SALT LAKE CITY, March 3, 2014-- Myriad Genetics, Inc. today announced that it has published data from the PROCEDE 500 study in the journal Current Medical Research and Opinion, demonstrating that 65 percent of physicians changed their original treatment plans for men with prostate cancer based on results from the Prolaris test.